(Q30955590)

English

A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

1 reference

Europe PubMed Central

A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

0 references

systematic review

1 reference

based on heuristic

inferred from title

Warren D. Taylor

1

object named as

Warren D Taylor

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

author name string

P Murali Doraiswamy

2

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

language of work or name

0 references

publication date

1 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

2285-2299

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Executive dysfunction and long-term outcomes of geriatric depression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Reconsidering Depression in the Elderly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Risk factors for suicide in later life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

The number needed to treat: a clinically useful measure of treatment effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

How to measure comorbidity. a critical review of available methods

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

A critical examination of the sensitivity of unidimensional subscales derived from the Hamilton Depression Rating Scale to antidepressant drug effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

The double-blind variable placebo lead-in period: results from two antidepressant clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Diagnostic Criteria for Use in Psychiatric Research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Depression following myocardial infarction. Impact on 6-month survival.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Single-blind comparison of venlafaxine and nortriptyline in elderly major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Response of depressive symptoms to nortriptyline, phenelzine and placebo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Course and rate of antidepressant response in the very old.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Sertraline treatment of major depression in patients with acute MI or unstable angina

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Depressive symptoms as relative and attributable risk factors for first-onset major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Epidemiology of depression in primary care

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

MRI-defined vascular depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Placebo in clinical trials for depression: complexity and necessity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Newer psychotropic medication use in nursing home residents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Diagnosis and treatment of depression in late life. Consensus statement update

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

The relationship between major and subthreshold variants of unipolar depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Placebos, drug effects, and study design: a clinician's guide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

When should a trial of fluoxetine for major depression be declared failed?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

An examination of the attitudes and practice of general practitioners in the diagnosis and treatment of depression in older people

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

The continuing unethical use of placebo controls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Depression and mortality in nursing homes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Depression, IV: STAR*D treatment trial for depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Measurement of serum estradiol levels in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Placebo response in studies of major depression: variable, substantial, and growing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Antidepressant versus placebo for depressed elderly.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Recovery in Geriatric Depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

21 January 2018

Placebo response in depression: a search for predictors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of placebos in randomized clinical trials of mood disorders: well justified, but improvements in design are indicated

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled treatment trial of depression in elderly physically ill patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

An NIMH perspective on the use of placebos. National Institute of Mental Health

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

Treating geriatric depression: a 26-week interim analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

Depression in Older Patients in Residential Care: Significance of Dysphoria and Dimensional Assessment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficient trial designs to reduce placebo requirements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

Moclobemide and nortriptyline in elderly depressed patients. A randomized, multicentre trial against placebo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

Depression and cardiac disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

Residual symptoms in depressed patients who respond acutely to fluoxetine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

Residual symptoms after partial remission: an important outcome in depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

Buspirone and imipramine for the treatment of major depression in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

Three- to 5-year prospective follow-up of outcome in major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

Bupropion sustained release versus paroxetine for the treatment of depression in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300550

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300550

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30955590&oldid=2175431175"